BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 18220274)

  • 1. Potential contribution of tumor suppressor p53 in the host defense against hepatitis C virus.
    Dharel N; Kato N; Muroyama R; Taniguchi H; Otsuka M; Wang Y; Jazag A; Shao RX; Chang JH; Adler MK; Kawabe T; Omata M
    Hepatology; 2008 Apr; 47(4):1136-49. PubMed ID: 18220274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of ethanol on innate antiviral pathways and HCV replication in human liver cells.
    Plumlee CR; Lazaro CA; Fausto N; Polyak SJ
    Virol J; 2005 Dec; 2():89. PubMed ID: 16324217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding the molecular mechanism(s) of hepatitis C virus (HCV) induced interferon resistance.
    Qashqari H; Al-Mars A; Chaudhary A; Abuzenadah A; Damanhouri G; Alqahtani M; Mahmoud M; El Sayed Zaki M; Fatima K; Qadri I
    Infect Genet Evol; 2013 Oct; 19():113-9. PubMed ID: 23831932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expressional screening of interferon-stimulated genes for antiviral activity against hepatitis C virus replication.
    Itsui Y; Sakamoto N; Kurosaki M; Kanazawa N; Tanabe Y; Koyama T; Takeda Y; Nakagawa M; Kakinuma S; Sekine Y; Maekawa S; Enomoto N; Watanabe M
    J Viral Hepat; 2006 Oct; 13(10):690-700. PubMed ID: 16970601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C virus replication in mouse cells is restricted by IFN-dependent and -independent mechanisms.
    Nandakumar R; Finsterbusch K; Lipps C; Neumann B; Grashoff M; Nair S; Hochnadel I; Lienenklaus S; Wappler I; Steinmann E; Hauser H; Pietschmann T; Kröger A
    Gastroenterology; 2013 Dec; 145(6):1414-23.e1. PubMed ID: 23973921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of hepatitis C virus replication by interferon regulatory factor 1.
    Kanazawa N; Kurosaki M; Sakamoto N; Enomoto N; Itsui Y; Yamashiro T; Tanabe Y; Maekawa S; Nakagawa M; Chen CH; Kakinuma S; Oshima S; Nakamura T; Kato T; Wakita T; Watanabe M
    J Virol; 2004 Sep; 78(18):9713-20. PubMed ID: 15331704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. (-)-Epigallocatechin-3-gallate enhances poly I:C-induced interferon-λ1 production and inhibits hepatitis C virus replication in hepatocytes.
    Wang YZ; Li JL; Wang X; Zhang T; Ho WZ
    World J Gastroenterol; 2017 Aug; 23(32):5895-5903. PubMed ID: 28932081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD40 inhibits replication of hepatitis C virus in primary human hepatocytes by c-Jun N terminal kinase activation independent from the interferon pathway.
    Rau SJ; Hildt E; Himmelsbach K; Thimme R; Wakita T; Blum HE; Fischer R
    Hepatology; 2013 Jan; 57(1):23-36. PubMed ID: 22814930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DDX60L Is an Interferon-Stimulated Gene Product Restricting Hepatitis C Virus Replication in Cell Culture.
    Grünvogel O; Esser-Nobis K; Reustle A; Schult P; Müller B; Metz P; Trippler M; Windisch MP; Frese M; Binder M; Fackler O; Bartenschlager R; Ruggieri A; Lohmann V
    J Virol; 2015 Oct; 89(20):10548-68. PubMed ID: 26269178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptional response of MxA, PKR and SOCS3 to interferon-based therapy in HCV genotype 4-infected patients and contribution of p53 to host antiviral response.
    Hamdi N; El-Akel W; El-Serafy M; Esmat G; Sarrazin C; Abdelaziz AI
    Intervirology; 2012; 55(3):210-8. PubMed ID: 21597279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C virus core protein down-regulates transcription of interferon-induced antiviral genes.
    de Lucas S; Bartolome J; Carreno V
    J Infect Dis; 2005 Jan; 191(1):93-9. PubMed ID: 15593009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C virus-mediated enhancement of microRNA miR-373 impairs the JAK/STAT signaling pathway.
    Mukherjee A; Di Bisceglie AM; Ray RB
    J Virol; 2015 Mar; 89(6):3356-65. PubMed ID: 25589644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Set7 facilitates hepatitis C virus replication via enzymatic activity-dependent attenuation of the IFN-related pathway.
    Han T; Wan Y; Wang J; Zhao P; Yuan Y; Wang L; She Y; Broering R; Lu M; Ye L; Zhu Y
    J Immunol; 2015 Mar; 194(6):2757-68. PubMed ID: 25681344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered expression and activation of signal transducers and activators of transcription (STATs) in hepatitis C virus infection: in vivo and in vitro studies.
    Larrea E; Aldabe R; Molano E; Fernandez-Rodriguez CM; Ametzazurra A; Civeira MP; Prieto J
    Gut; 2006 Aug; 55(8):1188-96. PubMed ID: 16120756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C virus replication is inhibited by 22beta-methoxyolean-12-ene-3beta, 24(4beta)-diol (ME3738) through enhancing interferon-beta.
    Hiasa Y; Kuzuhara H; Tokumoto Y; Konishi I; Yamashita N; Matsuura B; Michitaka K; Chung RT; Onji M
    Hepatology; 2008 Jul; 48(1):59-69. PubMed ID: 18459156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction between the HCV NS3 protein and the host TBK1 protein leads to inhibition of cellular antiviral responses.
    Otsuka M; Kato N; Moriyama M; Taniguchi H; Wang Y; Dharel N; Kawabe T; Omata M
    Hepatology; 2005 May; 41(5):1004-12. PubMed ID: 15841462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type III Interferon Induces Distinct SOCS1 Expression Pattern that Contributes to Delayed but Prolonged Activation of Jak/STAT Signaling Pathway: Implications for Treatment Non-Response in HCV Patients.
    Liu B; Chen S; Guan Y; Chen L
    PLoS One; 2015; 10(7):e0133800. PubMed ID: 26193702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type I interferon-mediated immune response against influenza A virus is attenuated in the absence of p53.
    Zhu Z; Yang Y; Wei J; Shao D; Shi Z; Li B; Liu K; Qiu Y; Zheng H; Ma Z
    Biochem Biophys Res Commun; 2014 Nov; 454(1):189-95. PubMed ID: 25450379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis C virus triggers apoptosis of a newly developed hepatoma cell line through antiviral defense system.
    Zhu H; Dong H; Eksioglu E; Hemming A; Cao M; Crawford JM; Nelson DR; Liu C
    Gastroenterology; 2007 Nov; 133(5):1649-59. PubMed ID: 17983809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of dual specificity phosphatase I expression inhibits hepatitis C virus replication.
    Choi JE; Kwon JH; Kim JH; Hur W; Sung PS; Choi SW; Yoon SK
    PLoS One; 2015; 10(3):e0119172. PubMed ID: 25798824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.